Southern Missouri Bancorp delivered a strong quarter with earnings of $1.83 per share, beating estimates by $0.31 on revenue of $51.77 million. However, the stock fell 1.4% to $75.41 as analysts remain divided and insider selling raises questions.
Source: MarketBeat · tickerreport.com
Pentair’s revised Q2 2026 guidance stunned investors, with EPS of $1.12 against a $1.48 estimate and revenue of $930M, well below the $1.1B consensus. The stock slid to $75.74 on heavy volume, its 200-day MA, and the new full-year EPS range of $4.60-4.80 implies a 10-14% miss, triggering a fresh round of analyst target cuts.
Source: MarketBeat · MarketBeat
Aehr Test Systems reported Q4 earnings of $0.05 per share, beating the consensus estimate of -$0.01 by $0.06. Despite negative net margins of -25.23% and insider selling, shares surged 5.9% to $72.01, with analysts mixed — two buys, one hold, one sell, and a Hold consensus with a $68 target.
Source: MarketBeat · tickerreport.com
Three corporate directors executed open-market purchases totaling $106,030 on June 11, signaling potential undervaluation at Eastern, Spire, and MasterBrand. The buys ranged from a 0.99% stake boost at Eastern to a 12.49% jump at MasterBrand, despite mixed earnings and sell-side downgrades.
Source: InsiderTrades com · InsiderTrades com
Codexis reported a significant Q4 2025 earnings beat, driven by its ECO Synthesis platform and expanding CDMO partnerships. Despite a raised 2026 revenue outlook and a surprise GAAP profit, analyst sentiment remains largely unchanged as the market awaits further commercial validation of its RNA manufacturing technology.
Wall Street Zen has lowered its ratings for Atlassian and ON Semiconductor to 'Hold,' reflecting a cooling sentiment toward high-growth tech and semiconductor leaders. The move comes as Atlassian navigates AI-driven restructuring and ON Semiconductor faces a maturing cycle in the automotive chip market.
Source: themarketsdaily.com · themarketsdaily.com
Wall Street Zen has issued 'Sell' ratings for both SAB Biotherapeutics and SURO Capital, signaling a shift in sentiment for high-risk biotech and venture-backed assets. These downgrades reflect growing analyst caution regarding clinical-stage development timelines and private equity valuation gaps in the 2026 market environment.
Alignment Healthcare's President and another insider divested over 33,000 shares in mid-March, following a massive secondary offering and a rating downgrade. The sales come as the Medicare Advantage provider reports narrowing losses but faces a shift in analyst sentiment from 'Buy' to 'Hold.'
Investment research platform Wall Street Zen has lowered its ratings for footwear distributor Weyco Group and home services provider Frontdoor to 'Hold.' The shift reflects a more cautious outlook on consumer discretionary spending and the housing-adjacent service sector as both companies face evolving market conditions.
Source: dailypolitical.com · dailypolitical.com
Investment research platform Wall Street Zen has issued dual upgrades for regional lender Lakeland Financial and networking firm ADTRAN. The ratings shift follows a significant earnings beat by ADTRAN and a stabilizing outlook for Indiana-based Lakeland Financial.
Source: tickerreport.com · tickerreport.com
Wall Street Zen has lowered its investment ratings for Alignment Healthcare and Freshworks from Buy to Hold, signaling a shift to a neutral outlook. The downgrades reflect a cautious stance on the Medicare Advantage sector and the competitive SaaS landscape as both companies navigate evolving market dynamics in early 2026.
Wall Street Zen has issued a series of ratings downgrades targeting a diverse group of companies including NanoVibronix, Cellebrite, MicroVision, and The Honest Company. These moves signal a shift in sentiment toward high-growth and speculative tech sectors as analysts re-evaluate valuation and performance metrics.
Wall Street Zen has lowered its ratings for luxury fashion house Tapestry and foodservice giant Sysco, signaling a more cautious stance on these sector leaders. The adjustments reflect shifting valuation dynamics and macroeconomic headwinds facing the consumer discretionary and staples sectors.
Source: dailypolitical.com · tickerreport.com
Analyst firm Wall Street Zen has issued significant rating upgrades for Weatherford International, Docebo, and Organogenesis. These shifts to 'Buy' and 'Strong-Buy' status signal a positive fundamental outlook across the energy, enterprise software, and healthcare sectors.
Wall Street Zen has downgraded both electronic manufacturing services provider Plexus (PLXS) and family safety platform Life360 (LIF) to Hold ratings. These shifts reflect a cautious stance on mid-cap growth and industrial tech as investors weigh valuation against near-term execution risks.
Source: defenseworld.net · defenseworld.net
Edgewise Therapeutics and Ericsson have both breached 52-week price peaks, signaling robust investor confidence in biotech innovation and telecom infrastructure recovery. While Edgewise benefits from clinical momentum in muscle disease treatments, Ericsson's ascent reflects a stabilized global 5G landscape and a strategic pivot toward AI-native networking.
Wall Street Zen has upgraded Medtronic, Reliance, and Element Solutions to 'Buy' ratings, signaling a bullish outlook across healthcare and industrial sectors. These upgrades reflect a strategic pivot toward high-quality dividend payers and market leaders as industrial demand stabilizes.
Source: dailypolitical.com · tickerreport.com